T1	Participants 35 52	anorexia nervosa.
T2	Participants 214 230	anorexia nervosa
T3	Participants 310 324	29 inpatients.
T4	Participants 655 666	both groups
T5	Participants 733 749	cisapride group;
T6	Participants 883 898	cisapride group
